Alberto Hayek, an emeritus professor at the University of California San Diego School of Medicine, is teaming up with John Glass from the J. Craig Venter Institute to engineer skin microbes into glucose monitors and insulin factories in the body. The project aims to tackle the increasing issue of diabetes, which affects approximately 8.4 million people in the U.S. While insulin treats symptoms of diabetes, use of engineered bacterial therapeutics, through skin microbes, could not only monitor glucose but also produce required insulin. The therapy would involve a gene instructing skin bacterium Staphylococcus epidermidis, found in almost everybody, to secrete insulin in response to high blood sugar levels. A subsequent, optional insulin lotion could be applied to the skin, further diffusing the bacteria into the bloodstream.

Getting Under the Skin Grow by Ginkgo

OpenAI's GPT Store, allowing sharing of custom chatbots, launched following delays. Since November's GPT Builder announcement, over 3 million chatbots have been user-generated. Initially planned for November, the delayed store allows only paid-tier subscribers to create and use custom GPTs. OpenAI plans to start a revenue sharing scheme with creators and has developed a review system for GPTs. Available to ChatGPT Plus, Enterprise and new 'Team' tier users, the store offers access to various GPT and data analysis features. Team subscriptions provide data privacy, custom GPT creation and usage. Pricing for Team is $25-$30 per user monthly, depending on billing cycle.

OpenAI’s custom GPT Store is now open for business The Verge

AI, digital health on rise in 2024. Optimizations sought for overworked healthcare staff and financial stress with tech solutions. AI seen as transformative but needs safety measures. Advice given for tech integration targeting efficiency, patient experience. AI could streamline non-clinical processes, control operating costs. Companies face lower valuations, reduced IPO interest, investment slowdown. Shifts needed for operational goals, focusing on health outcomes, cost management. Generative AI adoption progressing; workflow applications, EMRs might dominate uptake. Robust large language models in healthcare require careful implementation for accuracy, safety. Patient acceptance crucial; value of AI needs clear illustration. ePrescribing moving towards price transparency. Increased regulatory involvement expected as AI's application grows. Labor shortfall countered with automation enhancing efficiency. AI improvements in clinical documentation, billing promised. AI, data analytics advised for long-term strategy and financial health. Admin burdens reduced with AI, automation. Aging population, resource scarcity may drive healthcare innovation. Alternative EHR offerings providing competitive ROI foreseen. Generative AI could improve context of care, reduce rehospitalization, push value-based care. Executives advised to adopt technology as core strategy for growth.

Health technology in 2024: Projections for AI, digital health, and more Chief Healthcare Executive

2024 healthcare focuses on strengthening technology foundations after Covid-19 impact. Prioritizing necessary tech over novelty, healthcare organizations aim to streamline and optimize systems for efficiency and performance, benefiting telehealth and patient engagement. AI capabilities heavily influence this transformation. Increased tech-literacy within organizations and financial necessity also contribute. Despite 2023's funding slowdown leading to some startups closing, the industry remains optimistic, with recovery signs and new entities entering the healthcare sector, prompting organizations to emphasize their core strengths.

2024: The Year We Strengthen Our Healthcare Tech Foundations Forbes

Alberto Hayek, an emeritus professor at the University of California San Diego School of Medicine, is teaming up with John Glass from the J. Craig Venter Institute to engineer skin microbes into glucose monitors and insulin factories in the body. The project aims to tackle the increasing issue of diabetes, which affects approximately 8.4 million people in the U.S. While insulin treats symptoms of diabetes, use of engineered bacterial therapeutics, through skin microbes, could not only monitor glucose but also produce required insulin. The therapy would involve a gene instructing skin bacterium Staphylococcus epidermidis, found in almost everybody, to secrete insulin in response to high blood sugar levels. A subsequent, optional insulin lotion could be applied to the skin, further diffusing the bacteria into the bloodstream.

Getting Under the Skin Grow by Ginkgo

OpenAI's GPT Store, allowing sharing of custom chatbots, launched following delays. Since November's GPT Builder announcement, over 3 million chatbots have been user-generated. Initially planned for November, the delayed store allows only paid-tier subscribers to create and use custom GPTs. OpenAI plans to start a revenue sharing scheme with creators and has developed a review system for GPTs. Available to ChatGPT Plus, Enterprise and new 'Team' tier users, the store offers access to various GPT and data analysis features. Team subscriptions provide data privacy, custom GPT creation and usage. Pricing for Team is $25-$30 per user monthly, depending on billing cycle.

OpenAI’s custom GPT Store is now open for business The Verge

AI, digital health on rise in 2024. Optimizations sought for overworked healthcare staff and financial stress with tech solutions. AI seen as transformative but needs safety measures. Advice given for tech integration targeting efficiency, patient experience. AI could streamline non-clinical processes, control operating costs. Companies face lower valuations, reduced IPO interest, investment slowdown. Shifts needed for operational goals, focusing on health outcomes, cost management. Generative AI adoption progressing; workflow applications, EMRs might dominate uptake. Robust large language models in healthcare require careful implementation for accuracy, safety. Patient acceptance crucial; value of AI needs clear illustration. ePrescribing moving towards price transparency. Increased regulatory involvement expected as AI's application grows. Labor shortfall countered with automation enhancing efficiency. AI improvements in clinical documentation, billing promised. AI, data analytics advised for long-term strategy and financial health. Admin burdens reduced with AI, automation. Aging population, resource scarcity may drive healthcare innovation. Alternative EHR offerings providing competitive ROI foreseen. Generative AI could improve context of care, reduce rehospitalization, push value-based care. Executives advised to adopt technology as core strategy for growth.

Health technology in 2024: Projections for AI, digital health, and more Chief Healthcare Executive

2024 healthcare focuses on strengthening technology foundations after Covid-19 impact. Prioritizing necessary tech over novelty, healthcare organizations aim to streamline and optimize systems for efficiency and performance, benefiting telehealth and patient engagement. AI capabilities heavily influence this transformation. Increased tech-literacy within organizations and financial necessity also contribute. Despite 2023's funding slowdown leading to some startups closing, the industry remains optimistic, with recovery signs and new entities entering the healthcare sector, prompting organizations to emphasize their core strengths.

2024: The Year We Strengthen Our Healthcare Tech Foundations Forbes